Graduate School of Engineering, Osaka Prefecture UniversityAssociate Professor*Profile is at the time of the award.
2019Inamori Research GrantsScience & Engineering
I believe that the successful development of immune checkpoint inhibitors has increased general recognition of cancer immunotherapy. It has been reported, however, that immune checkpoint inhibitors do not work on a certain portion of patients, and one of the reasons for this is the inability to induce cancer-specific killer T cells. Now that we have the research grant, we will pursue basic research to save cancer patients who cannot benefit from current immunotherapy.
Science & Engineering